Literature DB >> 10821806

Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression.

D R Murray1, S D Prabhu, B Chandrasekar.   

Abstract

BACKGROUND: The sympathetic nervous system and proinflammatory cytokines are believed to play key roles in the pathophysiology of congestive heart failure. To evaluate a possible relationship between these neurohormonal systems, we studied the effects of chronic beta-adrenergic stimulation on the myocardial and systemic elaboration of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-6. METHODS AND
RESULTS: Male rats received either L-isoproterenol (2.4 mg. kg(-1). d(-1), n=8) or saline (n=7) via miniosmotic pumps for 7 days. Myocardial cytokine expression was analyzed by both Northern and Western blotting and localized in the tissue using immunohistochemistry. ELISA was performed to measure circulating levels of cytokines. In myocardium from control animals, neither TNF-alpha nor IL-1beta were detected, whereas IL-6 was present at very low levels. Isoproterenol led to a significant (P<0.01) increase in mRNA and protein expression of all 3 cytokines. Immunohistochemistry did not detect immunoreactivity for either cytokine in myocardium from controls; however, all 3 cytokines were readily detected (P<0.05) throughout the myocardium, localized to resident cells and vessels, in animals treated with isoproterenol. Neither treatment group had detectable levels of cytokines in the serum.
CONCLUSIONS: Chronic beta-adrenergic stimulation induces myocardial, but not systemic, elaboration of TNF-alpha, IL-1beta, and IL-6.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821806     DOI: 10.1161/01.cir.101.20.2338

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  49 in total

1.  Exercise training, inflammation and heart failure: working out to cool down.

Authors:  Eduard Guasch; Begoña Benito; Stanley Nattel
Journal:  J Physiol       Date:  2010-07-15       Impact factor: 5.182

2.  Pro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent.

Authors:  Laurel A Grisanti; Janel Evanson; Erica Marchus; Heather Jorissen; Andrew P Woster; Wanda DeKrey; Edward R Sauter; Colin K Combs; James E Porter
Journal:  Mol Immunol       Date:  2010-01-29       Impact factor: 4.407

3.  β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

Authors:  David R Murray; Srinivas Mummidi; Anthony J Valente; Tadashi Yoshida; Naveen K Somanna; Patrice Delafontaine; Charles A Dinarello; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2011-10-08       Impact factor: 5.000

Review 4.  A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk.

Authors:  Icilma V Fergus; Kenneth L Connell; Keith C Ferdinand
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

Review 5.  Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).

Authors:  Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

Review 6.  Innate immunity and the failing heart: the cytokine hypothesis revisited.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

7.  Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.

Authors:  Laurel A Grisanti; Ashley A Repas; Jennifer A Talarico; Jessica I Gold; Rhonda L Carter; Walter J Koch; Douglas G Tilley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 8.  Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

Authors:  Mario Cazzola; Maria G Matera; Claudio F Donner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 9.  Bench-to-bedside review: Beta-adrenergic modulation in sepsis.

Authors:  Etienne de Montmollin; Jerome Aboab; Arnaud Mansart; Djillali Annane
Journal:  Crit Care       Date:  2009-10-23       Impact factor: 9.097

Review 10.  Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety.

Authors:  Andrea Rossi; Sonia Khirani; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.